Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential”

1,615 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,615 results

Not applicableLooking for participantsNCT06899022
What this trial is testing

Attention and Eye Movement in Parkinson's Disease

Who this might be right for
Essential TremorParkinson's Disease (PD)
University of Nebraska 138
Not applicableStudy completedNCT07257237
What this trial is testing

Sleep Hygiene Education and Blood Pressure Control in Essential Hypertension in Primary Care

Who this might be right for
Essential HypertensionSleep QualityPrimary Care
Ozturk Gurer Tutu, MD 138
Large-scale testing (Phase 3)Looking for participantsNCT06079879
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Who this might be right for
Essential Thrombocythemia
Merck Sharp & Dohme LLC 340
Not applicableUnknownNCT03116542
What this trial is testing

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia

Who this might be right for
Essential ThrombocythemiaPrimary Myelofibrosis, Fibrotic StagePrimary Myelofibrosis, Prefibrotic Stage
Hamad Medical Corporation 21
Not applicableStudy completedNCT00940966
What this trial is testing

A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome

Who this might be right for
Elevated TriglyceridesSystolic HypertensionInsulin Resistance+1 more
CAMC Health System 40
Post-approval studies (Phase 4)Study completedNCT02495324
What this trial is testing

Fimasartan Achieving SBP Target (FAST) Study

Who this might be right for
Essential,Hypertension
Boryung Pharmaceutical Co., Ltd 369
Post-approval studies (Phase 4)UnknownNCT01825759
What this trial is testing

Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

Who this might be right for
Coronary Heart DiseaseEssential Hypertension
West China Hospital 200
Not applicableStudy completedNCT02238262
What this trial is testing

Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Who this might be right for
Hypertension
Boehringer Ingelheim 2,318
Testing effectiveness (Phase 2)Ended earlyNCT02226172
What this trial is testing

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Who this might be right for
Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Pfizer 21
Not applicableUnknownNCT03015311
What this trial is testing

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

Who this might be right for
Primary Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 8,000
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Large-scale testing (Phase 3)Study completedNCT03952039
What this trial is testing

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraMyelofibrosis
Celgene 202
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT01909531
What this trial is testing

Deep Brain Stimulation (DBS) Data Base Study

Who this might be right for
Parkinson's DiseaseEssential Tremor
St. Joseph's Hospital and Medical Center, Phoenix 5,000
Large-scale testing (Phase 3)Study completedNCT00624065
What this trial is testing

Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

Who this might be right for
Hypertension
GlaxoSmithKline 348
Testing effectiveness (Phase 2)Study completedNCT00006367
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myeloproliferative Disorders
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00623337
What this trial is testing

Ghana Newborn Home Visits Neonatal Mortality Trial

Who this might be right for
Neonatal Mortality
London School of Hygiene and Tropical Medicine 15,000
Testing effectiveness (Phase 2)Study completedNCT00102596
What this trial is testing

Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor

Who this might be right for
Essential Tremor
National Institute of Neurological Disorders and Stroke (NINDS) 21
Post-approval studies (Phase 4)UnknownNCT02267239
What this trial is testing

Methodology Antiseptic Application, Influence on Oral Biofilm.

Who this might be right for
Oral BiofilmPeriodontitisGingivitis
University of Santiago de Compostela 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01787487
What this trial is testing

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more
M.D. Anderson Cancer Center
Load More Results
121